GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment Post date 23 July 2024 ← Rivaroxaban: Lancet is under pressure to retract “unreliable” paper as investigation drags on → Women’s representation and limitations of quotas